These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34614422)

  • 1. The association between hippocampal volume and memory in pathological aging is mediated by functional redundancy.
    Langella S; Mucha PJ; Giovanello KS; Dayan E;
    Neurobiol Aging; 2021 Dec; 108():179-188. PubMed ID: 34614422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between performance on the Cogstate Brief Battery, neurodegeneration, and Aβ accumulation in cognitively normal older adults and adults with MCI.
    Lim YY; Pietrzak RH; Bourgeat P; Ames D; Ellis KA; Rembach A; Harrington K; Salvado O; Martins RN; Snyder PJ; Masters CL; Rowe CC; Villemagne VL; Maruff P
    Arch Clin Neuropsychol; 2015 Feb; 30(1):49-58. PubMed ID: 25467942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
    Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
    Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship of functional hippocampal activity, amyloid deposition, and longitudinal memory decline to memory complaints in cognitively healthy older adults.
    Chen X; Farrell ME; Rundle MM; Chan MY; Moore W; Wig GS; Park DC
    Neurobiol Aging; 2021 Sep; 105():318-326. PubMed ID: 34147860
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Independent contribution of temporal beta-amyloid deposition to memory decline in the pre-dementia phase of Alzheimer's disease.
    Chételat G; Villemagne VL; Pike KE; Ellis KA; Bourgeat P; Jones G; O'Keefe GJ; Salvado O; Szoeke C; Martins RN; Ames D; Masters CL; Rowe CC;
    Brain; 2011 Mar; 134(Pt 3):798-807. PubMed ID: 21310725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal trajectory of Amyloid-related hippocampal subfield atrophy in nondemented elderly.
    Zhang L; Mak E; Reilhac A; Shim HY; Ng KK; Ong MQW; Ji F; Chong EJY; Xu X; Wong ZX; Stephenson MC; Venketasubramanian N; Tan BY; O'Brien JT; Zhou JH; Chen CLH;
    Hum Brain Mapp; 2020 Jun; 41(8):2037-2047. PubMed ID: 31944479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amyloid-β deposition in mild cognitive impairment is associated with increased hippocampal activity, atrophy and clinical progression.
    Huijbers W; Mormino EC; Schultz AP; Wigman S; Ward AM; Larvie M; Amariglio RE; Marshall GA; Rentz DM; Johnson KA; Sperling RA
    Brain; 2015 Apr; 138(Pt 4):1023-35. PubMed ID: 25678559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cognitive dispersion is a sensitive marker for early neurodegenerative changes and functional decline in nondemented older adults.
    Bangen KJ; Weigand AJ; Thomas KR; Delano-Wood L; Clark LR; Eppig J; Werhane ML; Edmonds EC; Bondi MW
    Neuropsychology; 2019 Jul; 33(5):599-608. PubMed ID: 30896235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recognition Memory Dysfunction Relates to Hippocampal Subfield Volume: A Study of Cognitively Normal and Mildly Impaired Older Adults.
    Bennett IJ; Stark SM; Stark CEL
    J Gerontol B Psychol Sci Soc Sci; 2019 Sep; 74(7):1132-1141. PubMed ID: 29401233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease.
    Richter N; Bischof GN; Dronse J; Nellessen N; Neumaier B; Langen KJ; Drzezga A; Fink GR; van Eimeren T; Kukolja J; Onur OA
    J Alzheimers Dis; 2020; 78(4):1601-1614. PubMed ID: 33164934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Episodic memory loss is related to hippocampal-mediated beta-amyloid deposition in elderly subjects.
    Mormino EC; Kluth JT; Madison CM; Rabinovici GD; Baker SL; Miller BL; Koeppe RA; Mathis CA; Weiner MW; Jagust WJ;
    Brain; 2009 May; 132(Pt 5):1310-23. PubMed ID: 19042931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Alzheimer disease with β-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing.
    Rowe CC; Bourgeat P; Ellis KA; Brown B; Lim YY; Mulligan R; Jones G; Maruff P; Woodward M; Price R; Robins P; Tochon-Danguy H; O'Keefe G; Pike KE; Yates P; Szoeke C; Salvado O; Macaulay SL; O'Meara T; Head R; Cobiac L; Savage G; Martins R; Masters CL; Ames D; Villemagne VL
    Ann Neurol; 2013 Dec; 74(6):905-13. PubMed ID: 24448836
    [TBL] [Abstract][Full Text] [Related]  

  • 13. One-year Follow-up Study of Hippocampal Subfield Atrophy in Alzheimer's Disease and Normal Aging.
    Madusanka N; Choi HK; So JH; Choi BK; Park HG
    Curr Med Imaging Rev; 2019; 15(7):699-709. PubMed ID: 32008518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.
    Hohman TJ; Bell SP; Jefferson AL;
    JAMA Neurol; 2015 May; 72(5):520-9. PubMed ID: 25751166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lower functional hippocampal redundancy in mild cognitive impairment.
    Langella S; Sadiq MU; Mucha PJ; Giovanello KS; Dayan E;
    Transl Psychiatry; 2021 Jan; 11(1):61. PubMed ID: 33462184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of brain atrophy subtypes during aging predicts long-term cognitive decline and future Alzheimer's clinical syndrome.
    Planche V; Coupé P; Helmer C; Le Goff M; Amieva H; Tison F; Dartigues JF; Catheline G
    Neurobiol Aging; 2019 Jul; 79():22-29. PubMed ID: 31026619
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hippocampal subregional volume changes in elders classified using positron emission tomography-based Alzheimer's biomarkers of β-amyloid deposition and neurodegeneration.
    Busatto Filho G; Duran FLS; Squarzoni P; Coutinho AMN; Rosa PGP; Torralbo L; Pachi CGDF; da Costa NA; Porto FHG; Carvalho CL; Brucki SMD; Nitrini R; Forlenza OV; Leite CDC; Buchpiguel CA; de Paula Faria D
    J Neurosci Res; 2021 Feb; 99(2):481-501. PubMed ID: 33073383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatial correlation maps of the hippocampus with cerebrospinal fluid biomarkers and cognition in Alzheimer's disease: A longitudinal study.
    Liu G; Liu C; Qiu A;
    Hum Brain Mapp; 2021 Jun; 42(9):2931-2940. PubMed ID: 33739550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Memory decline in elderly with cerebral small vessel disease explained by temporal interactions between white matter hyperintensities and hippocampal atrophy.
    van Leijsen EMC; Tay J; van Uden IWM; Kooijmans ECM; Bergkamp MI; van der Holst HM; Ghafoorian M; Platel B; Norris DG; Kessels RPC; Markus HS; Tuladhar AM; de Leeuw FE
    Hippocampus; 2019 Jun; 29(6):500-510. PubMed ID: 30307080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variables associated with hippocampal atrophy rate in normal aging and mild cognitive impairment.
    Nosheny RL; Insel PS; Truran D; Schuff N; Jack CR; Aisen PS; Shaw LM; Trojanowski JQ; Weiner MW;
    Neurobiol Aging; 2015 Jan; 36(1):273-82. PubMed ID: 25175807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.